Ukraine Secures COVID-19 Vaccine Supplies from Global Manufacturers

Ukrainian President Volodymyr Zelensky announced on Monday that the country has reached agreements with four major pharmaceutical companies, including Pfizer, Sinovac, AstraZeneca, and Novavax, to obtain COVID-19 vaccines. This significant development comes as Ukraine prepares to launch its vaccination campaign, with the first stage targeting medical professionals, military personnel, and national guard members. The country aims to inoculate at least half of its population by the end of 2021 and early 2022.

Key Takeaways:

• Ukraine has secured agreements with four major pharmaceutical companies, including Pfizer, Sinovac, AstraZeneca, and Novavax, to obtain COVID-19 vaccines.
• The vaccination campaign will begin in February, with approximately 367,500 people targeted for inoculation during the first stage.
• Ukrainian President Volodymyr Zelensky emphasized the importance of vaccination, stating that it is essential, safe, and important to the country's response to the pandemic.
• The vaccination roadmap guarantees equal access to vaccines for all Ukrainian citizens and aims to cover at least half of the population by the end of 2021 and early 2022.
• Ukrainian Health Minister Maxym Stepanov reiterated that Russia's Sputnik V coronavirus vaccine will not be approved in Ukraine.
• The country faces a significant challenge in addressing vaccine mistrust and refusal among a significant portion of its population.

Statistics:

• Ukraine aims to vaccinate at least half of its population by the end of 2021 and early 2022.
• Approximately 367,500 people are targeted for inoculation during the first stage of the vaccination campaign.
• Ukraine has secured agreements with four major pharmaceutical companies to obtain COVID-19 vaccines.

Sources:

• Interfax. "Ukraine expects supplies of coronavirus vaccines from Pfizer, Sinovac, AstraZeneca, Novavax," February 8